Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose Finding and Pharmacokinetic Study of the Intravenous Camptothecin ST1968 in Patients With Solid Tumors

NCT01748019 is registered in ClinicalTrials.gov with sigma-tau i.f.r. S.p.A. as lead sponsor.

NCT NCT01748019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01748019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose Finding and Pharmacokinetic Study of the Intravenous Camptothecin ST1968 in Patients With Solid Tumors
Lead sponsor
sigma-tau i.f.r. S.p.A.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2007
Completion date
December 31, 2011
Enrollment
62 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors